Stay ahead of the curve in Asia’s rapidly expanding ADC landscape with the 4th World ADC Asia Summit. The official event guide is your essential resource for navigating the most comprehensive ADC platform in the region.
Download the eBook
With three dynamic tracks covering discovery, preclinical, clinical, and CMC, plus exclusive seminar days on ADC fundamentals and Bispecific ADCs, this guide ensures you gain critical insights and make the right connections.
Download your copy now and position yourself at the forefront of Asia’s ADC revolution.
Download the eBook
About Hanson Wade Group - World ADC Asia
Following Isen's groundbreaking $1B+ ADC deal with China-based Foreseen Biotechnology, the rapid rise of new companies, billions of dollars in investments, and a surge in partnerships involving Asian firms continue to capture the world’s attention. All eyes are now focused on the clinical validation of the next big leap in ADC technologies.
In response to this momentum, the 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community. This summit brings together cutting-edge innovators from Asia and the expertise of the West to chart a path to ADC success across the region.
This year, we’re introducing 3 dynamic tracks covering discovery, preclinical, clinical, and CMC, alongside exclusive seminar days focusing on ADC fundamentals and Bispecific ADCs. Whether you're just starting out or a seasoned expert, the program offers something for professionals at every level.
Don’t miss this opportunity to gain a complete view of the ADC landscape in Asia. You’ll have access to insightful sessions on novel design trends, emerging clinical data, and strategic partnering and licensing decisions. Plus, connect with over 60+ industry-leading speakers from top companies such as AstraZeneca, Daiichi Sankyo, leading Asian ADC biotechs, innovative start-ups, and top-tier ADC service providers from around the globe.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.